Virgilio De Stefano
Marche Polytechnic University, Ng Teng Fong General Hospital
Papers
7
Total Citations
137
H-Index
6
About
Dr. Virgilio De Stefano is a rising leader in urologic oncology and minimally invasive surgery, whose work is rapidly shaping the future of prostate and kidney cancer care. His research centers on three transformative pillars: focal therapy for prostate cancer, the integration of artificial intelligence (AI) and robotics in urology, and advanced surgical techniques for benign and malignant conditions. Dr. De Stefano’s major contributions include two landmark systematic reviews on focal therapy, which together have garnered nearly 80 citations, providing a rigorous, evidence-based definition of cancer control and a comprehensive assessment of functional outcomes and patient-reported measures. He has also been at the forefront of evaluating AI’s role in robotic-assisted radical prostatectomy and percutaneous nephrolithotripsy, publishing forward-looking reviews that map the potential of machine learning to enhance surgical precision and decision-making. His work extends to novel treatments like Aquablation for benign prostatic hyperplasia and innovative imaging techniques such as near-infrared fluorescence with indocyanine green for partial nephrectomy. Through these impactful, high-citation systematic reviews, Dr. De Stefano is establishing the benchmarks for next-generation, patient-centered urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7